carteolol has been researched along with Leukoma in 1 studies
Carteolol: A beta-adrenergic antagonist used as an anti-arrhythmia agent, an anti-angina agent, an antihypertensive agent, and an antiglaucoma agent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Igarashi, H | 1 |
| Katsuta, Y | 1 |
| Sawa, K | 1 |
| Nakazato, Y | 1 |
| Kawasaki, T | 1 |
1 other study available for carteolol and Leukoma
| Article | Year |
|---|---|
A comparison of the opacifying effects of carteolol.HCl and 8-hydroxycarteolol.HCl in the isolated porcine cornea.
Topics: Animals; Benzalkonium Compounds; Carteolol; Corneal Opacity; Propanolamines; Swine | 1990 |